2b2x: Difference between revisions
New page: left|200px<br /> <applet load="2b2x" size="450" color="white" frame="true" align="right" spinBox="true" caption="2b2x, resolution 2.200Å" /> '''VLA1 RdeltaH I-dom... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2b2x.gif|left|200px]]<br /> | [[Image:2b2x.gif|left|200px]]<br /><applet load="2b2x" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2b2x" size=" | |||
caption="2b2x, resolution 2.200Å" /> | caption="2b2x, resolution 2.200Å" /> | ||
'''VLA1 RdeltaH I-domain complexed with a quadruple mutant of the AQC2 Fab'''<br /> | '''VLA1 RdeltaH I-domain complexed with a quadruple mutant of the AQC2 Fab'''<br /> | ||
==Overview== | ==Overview== | ||
Improving the affinity of a high-affinity protein-protein interaction is a | Improving the affinity of a high-affinity protein-protein interaction is a challenging problem that has practical applications in the development of therapeutic biomolecules. We used a combination of structure-based computational methods to optimize the binding affinity of an antibody fragment to the I-domain of the integrin VLA1. Despite the already high affinity of the antibody (Kd approximately 7 nM) and the moderate resolution (2.8 A) of the starting crystal structure, the affinity was increased by an order of magnitude primarily through a decrease in the dissociation rate. We determined the crystal structure of a high-affinity quadruple mutant complex at 2.2 A. The structure shows that the design makes the predicted contacts. Structural evidence and mutagenesis experiments that probe a hydrogen bond network illustrate the importance of satisfying hydrogen bonding requirements while seeking higher-affinity mutations. The large and diverse set of interface mutations allowed refinement of the mutant binding affinity prediction protocol and improvement of the single-mutant success rate. Our results indicate that structure-based computational design can be successfully applied to further improve the binding of high-affinity antibodies. | ||
==About this Structure== | ==About this Structure== | ||
2B2X is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with MG as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | 2B2X is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with <scene name='pdbligand=MG:'>MG</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2B2X OCA]. | ||
==Reference== | ==Reference== | ||
Line 15: | Line 14: | ||
[[Category: Rattus norvegicus]] | [[Category: Rattus norvegicus]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Boriack-Sjodin, P | [[Category: Boriack-Sjodin, P A.]] | ||
[[Category: Clark, L | [[Category: Clark, L A.]] | ||
[[Category: Eldredge, J.]] | [[Category: Eldredge, J.]] | ||
[[Category: Fitch, C.]] | [[Category: Fitch, C.]] | ||
[[Category: Friedman, B.]] | [[Category: Friedman, B.]] | ||
[[Category: Hanf, K | [[Category: Hanf, K J.]] | ||
[[Category: Jarpe, M.]] | [[Category: Jarpe, M.]] | ||
[[Category: Li, Y.]] | [[Category: Li, Y.]] | ||
[[Category: Liparoto, S | [[Category: Liparoto, S F.]] | ||
[[Category: Lugovskoy, A.]] | [[Category: Lugovskoy, A.]] | ||
[[Category: MG]] | [[Category: MG]] | ||
Line 29: | Line 28: | ||
[[Category: computational design]] | [[Category: computational design]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:33:35 2008'' |